Metabolomic analysis of an estrogen receptor positive breast cancer cell line made resistant to doxorubicin revealed heightened incorporation of glutamine into the TCA cycle compared to that observed in sensitive cells (McGuirk et al., 2021). The gene discussed is ESR1; the disease is breast carcinoma.